Paul Davies is a physicist turned Brave Maverick Cancer Researcher who thinks that, as an outsider, he’s had an insight to the origin of cancer. The problem is that his “insight” is 100 years old. Scientists rejected it long ago because it doesn’t fit with the evidence and produces no promising strategies to improve cancer care. Naturally, Davies cries “Big pharma!”
Cassandra Callender made national news a couple of years ago when at age 17 she was diagnosed with Hodgkin’s lymphoma and refused chemotherapy. The court ordered that she undergo appropriate treatment, but unfortunately she relapsed and chose treatment at a quack clinic in Mexico. Continuing to progress, she finally chose real medicine to treat her cancer. Let’s hope that it’s not too late to save her.
Since being given a slap on the wrist by the Texas Medical Board for his many years of peddling his antineoplastons, a treatment that’s never been shown to have significant anticancer activity, Stanislaw Burzynski is back in action again, preying on desperate cancer patients like it’s 1999.
This week, the FDA sent warning letters to 14 companies making unsupported claims that their products can treat cancer. Given the new administration’s determination to deregulate almost everything, but especially the FDA, is this the last time in the foreseeable future that such a crackdown will occur?
Ill-advised right-to-try bills are spreading like kudzu through state legislatures. Now federal legislators want to insert right-to-try language into the bill that funds FDA drug approval. Given the support of powerful Republicans for right-to-try, is it too late to stop this juggernaut and protect patients?
